About Balt Group
Balt Group is a company based in Montmorency (France) founded in 1977. It operates as a Direct-to-Consumer (D2C). The company has 50 employees as of October 31, 2024. Balt Group offers products and services including Neurovascular Devices and Peripheral Embolization Products. Balt Group operates in a competitive market with competitors including Route 92 Medical, Autonomix, Balt, Shenzhen Yinghe Brain Science and Neuro Front, among others.
- Headquarter Montmorency, France
- Employees 50 as on 31 Oct, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$38.65 K (USD)-4as on Dec 31, 2023
-
Net Profit
$2.81 K (USD)431as on Dec 31, 2023
-
EBITDA
Not available
-
Latest Funding Round
$488.62 K (USD), Grant
May 19, 2021
- Investors
-
Employee Count
50
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Balt Group
Balt Group offers a comprehensive portfolio of products and services, including Neurovascular Devices and Peripheral Embolization Products.
Devices for ischemic and hemorrhagic stroke are provided.
Solutions for peripheral vascular embolization are offered here.
People of Balt Group
Unlock access to complete
Funding Insights of Balt Group
Investors in Balt Group
Balt Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Balt Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Balt Group
Investment portfolio details for Balt Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Balt Group
Detailed financials for Balt Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Balt Group Comparisons
Peer comparison for Balt Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Balt Group
Balt Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Route 92 Medical, Autonomix, Balt, Shenzhen Yinghe Brain Science and Neuro Front, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation products for neurointerventional procedures are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices for vascular malformations are developed.
|
|
| Locked | Locked | Locked |
Neuromodulation devices and brain-computer interfaces for neurological treatments are developed.
|
|
| Locked | Locked | Locked |
Transformation medicines and neuromodulation devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Injectable neurostimulation devices are developed for neurological treatments.
|
Detailed competitors of Balt Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Balt Group
Complete news archive for Balt Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balt Group
Balt Group was founded in 1977 and raised its 1st funding round 44 years after it was founded.
Balt Group is headquartered in Montmorency, France. It is registered at Montmorency, Ile-de-france, France.
Pascal Girin is the current CEO of Balt Group.
As of Oct 31, 2024, the latest employee count at Balt Group is 50.
Annual revenue of Balt Group is $38.65K as on Dec 31, 2023.
Balt Group is recognized for pioneering neurovascular intervention devices since 1977. The company is focused on creating physician-inspired, patient-focused solutions for ischemic and hemorrhagic stroke. Additionally, innovation is extended into the peripheral vascular space, offering a broad portfolio of medical devices. Collaboration with physicians and institutions is maintained to develop elegant solutions. A commitment to sustainability is emphasized for the planet, people, products, and patients served. The mission is driven by a dedicated team working across multiple global offices.
Balt Group's top competitors include Route 92 Medical, Autonomix and Magnendo.
Balt Group offers Neurovascular Devices and Peripheral Embolization Products.
Balt Group has 1 investor. Key investors include Ministry of Economy, Finance and Industrial and Digital Sovereignty.